Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription

Articles published in Exp Cell Res

Retrieve available abstracts of 40 articles:
HTML format

Single Articles

    July 2021
  1. HUANG W, Chen J, Liu X, Liu X, et al
    MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.
    Exp Cell Res. 2021 Jul 6:112722. doi: 10.1016/j.yexcr.2021.112722.
    PubMed     Abstract available

    June 2021
  2. ZHU B, Zhang X, Sun S, Fu Y, et al
    NF-kappaB and neutrophil extracellular traps cooperate to promote breast cancer progression and metastasis.
    Exp Cell Res. 2021;405:112707.
    PubMed     Abstract available

    March 2021
  3. SHI X, Sun Y, Zhang Y, Wang W, et al
    MEX3A Promotes development and progression of breast cancer through regulation of PIK3CA.
    Exp Cell Res. 2021 Mar 31:112580. doi: 10.1016/j.yexcr.2021.112580.
    PubMed     Abstract available

    February 2021
  4. NAIR MG, Somashekaraiah VM, Ramamurthy V, Prabhu JS, et al
    miRNAs: Critical mediators of breast cancer metastatic programming.
    Exp Cell Res. 2021 Feb 16:112518. doi: 10.1016/j.yexcr.2021.112518.
    PubMed     Abstract available

    January 2021
  5. REN K, Zhou D, Wang M, Li E, et al
    RACGAP1 Modulates ECT2-Dependent Mitochondrial Quality Control to Drive Breast Cancer Metastasis.
    Exp Cell Res. 2021 Jan 21:112493. doi: 10.1016/j.yexcr.2021.112493.
    PubMed     Abstract available

    October 2020
  6. ZHANG W, Veisaga ML, Barbieri MA
    Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.
    Exp Cell Res. 2020;396:112318.
    PubMed     Abstract available

  7. WU G, Zhou H, Li D, Zhi Y, et al
    LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Exp Cell Res. 2020;396:112331.
    PubMed     Abstract available

    September 2020
  8. DIMRI S, Malhotra R, Shet T, Mokal S, et al
    Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer.
    Exp Cell Res. 2020 Sep 28:112313. doi: 10.1016/j.yexcr.2020.112313.
    PubMed     Abstract available

  9. UMAR SM, Kashyap A, Kahol S, Mathur S, et al
    Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
    Exp Cell Res. 2020 Sep 10:112282. doi: 10.1016/j.yexcr.2020.112282.
    PubMed     Abstract available

    July 2020
  10. JIANG S, Meng L, Chen X, Liu H, et al
    MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.
    Exp Cell Res. 2020 Jul 29:112191. doi: 10.1016/j.yexcr.2020.112191.
    PubMed     Abstract available

  11. CHEN X, Wu C, Zhong J, Shen Y, et al
    Tumorigenesis and Progression As A Consequence of Hypoxic TMEA Prospective View upon Breast Cancer Therapeutic Targets.
    Exp Cell Res. 2020 Jul 29:112192. doi: 10.1016/j.yexcr.2020.112192.
    PubMed     Abstract available

    June 2020
  12. LIU JH, Chen C, Li ZY, Zou ZM, et al
    The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3beta and MyD88/NF-kappaB signalling pathways.
    Exp Cell Res. 2020 Jun 28:112157. doi: 10.1016/j.yexcr.2020.112157.
    PubMed     Abstract available

  13. RASHA F, Ramalingam L, Menikdiwela K, Hernandez A, et al
    Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions.
    Exp Cell Res. 2020 Jun 3:112114. doi: 10.1016/j.yexcr.2020.112114.
    PubMed     Abstract available

    April 2020
  14. CHEN Y, Du M, Yusuying S, Liu W, et al
    Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27(Kip1).
    Exp Cell Res. 2020 Apr 30:112038. doi: 10.1016/j.yexcr.2020.112038.
    PubMed     Abstract available

  15. JING X, Shao S, Zhang Y, Luo A, et al
    BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer.
    Exp Cell Res. 2020 Apr 24:112034. doi: 10.1016/j.yexcr.2020.112034.
    PubMed     Abstract available

  16. YANG SS, Ma S, Dou H, Liu F, et al
    Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Exp Cell Res. 2020 Apr 5:111983. doi: 10.1016/j.yexcr.2020.111983.
    PubMed     Abstract available

    March 2020
  17. GUNNARSDOTTIR FB, Hagerling C, Bergenfelz C, Mehmeti M, et al
    Inflammatory macrophage derived TNFalpha downregulates estrogen receptor alpha via FOXO3a inactivation in human breast cancer cells.
    Exp Cell Res. 2020 Mar 4:111932. doi: 10.1016/j.yexcr.2020.111932.
    PubMed     Abstract available

    December 2019
  18. LI Q, Cao J, He Y, Liu X, et al
    R5, a neutralizing antibody to Robo1, suppresses breast cancer growth and metastasis by inhibiting angiogenesis via down-regulating filamin A.
    Exp Cell Res. 2019 Dec 4:111756. doi: 10.1016/j.yexcr.2019.111756.
    PubMed     Abstract available

    November 2019
  19. XIAO W, Liu X, Niu X, Li C, et al
    The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
    Exp Cell Res. 2019 Nov 23:111743. doi: 10.1016/j.yexcr.2019.111743.
    PubMed     Abstract available

    September 2019
  20. HUANG D, Pei Y, Dai C, Huang Y, et al
    Up-regulated ADP-Ribosylation factor 3 promotes breast cancer cell proliferation through the participation of FOXO1.
    Exp Cell Res. 2019 Sep 17:111624. doi: 10.1016/j.yexcr.2019.111624.
    PubMed     Abstract available

    August 2019
  21. RAVI M, Sneka MK, Joshipura A
    The culture conditions and outputs from breast cancer cell line in vitro experiments.
    Exp Cell Res. 2019 Aug 6:111548. doi: 10.1016/j.yexcr.2019.111548.
    PubMed     Abstract available

    May 2019
  22. FOURIE C, Davis T, Kriel J, Engelbrecht AM, et al
    The paracrine effects of fibroblasts on doxorubicin-treated breast cancer cells.
    Exp Cell Res. 2019 May 20. pii: S0014-4827(19)30261.
    PubMed     Abstract available

  23. TAN S, Natasa B, Wong ESP, Lin VCL, et al
    Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells MCF-7.
    Exp Cell Res. 2019 May 14. pii: S0014-4827(19)30255.
    PubMed     Abstract available

    April 2019
  24. ZHOU R, Wang S, Wen H, Wang M, et al
    The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models.
    Exp Cell Res. 2019 Apr 26. pii: S0014-4827(19)30209.
    PubMed     Abstract available

  25. ZHANG ZG, Zhang HS, Sun HL, Liu HY, et al
    KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming.
    Exp Cell Res. 2019 Apr 9. pii: S0014-4827(19)30156.
    PubMed     Abstract available

    March 2019
  26. LI D, Wang X, Yang M, Kan Q, et al
    miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
    Exp Cell Res. 2019 Mar 20. pii: S0014-4827(19)30126.
    PubMed     Abstract available

    July 2018
  27. CHEN JH, Kuo KT, Bamodu OA, Lin YC, et al
    Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Exp Cell Res. 2018 Jul 4. pii: S0014-4827(18)30398.
    PubMed     Abstract available

    May 2018
  28. DING J, Xu Z, Zhang Y, Tan C, et al
    Exosome-mediated miR-222 Transferring: An insight into NF-kappaB-mediated Breast Cancer Metastasis.
    Exp Cell Res. 2018 May 17. pii: S0014-4827(18)30276.
    PubMed     Abstract available

    April 2018
  29. ROYSTON KJ, Paul B, Nozell S, Rajbhandari R, et al
    Withaferin A and Sulforaphane Regulate Breast Cancer Cell Cycle Progression through Epigenetic Mechanisms.
    Exp Cell Res. 2018 Apr 21. pii: S0014-4827(18)30226.
    PubMed     Abstract available

    March 2018
  30. LI C, Fan Q, Quan H, Nie M, et al
    The three branches of the unfolded protein response exhibit differential significance in breast cancer growth and stemness.
    Exp Cell Res. 2018 Mar 27. pii: S0014-4827(18)30183.
    PubMed     Abstract available

  31. LI K, Yan H, Guo W, Tang M, et al
    ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.
    Exp Cell Res. 2018 Mar 6. pii: S0014-4827(18)30125.
    PubMed     Abstract available

  32. YAMASHITA N, Saito N, Zhao S, Terai K, et al
    Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.
    Exp Cell Res. 2018 Mar 1. pii: S0014-4827(18)30116.
    PubMed     Abstract available

    January 2018
  33. MOREIRA MP, da Conceicao Braga L, Cassali GD, Silva LM, et al
    STAT3 as a promising chemoresistance biomarker associated with the CD44(+/high)/CD24(-/low)/ALDH(+) BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line.
    Exp Cell Res. 2018 Jan 15. pii: S0014-4827(18)30027.
    PubMed     Abstract available

  34. HUANG Y, Yang L, Pei YY, Wang J, et al
    Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway.
    Exp Cell Res. 2018 Jan 4. pii: S0014-4827(18)30003.
    PubMed     Abstract available

  35. LUO CW, Wu CC, Chang SJ, Chang TM, et al
    CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Exp Cell Res. 2018 Jan 3. pii: S0014-4827(17)30695.
    PubMed     Abstract available

    December 2017
  36. GONG XF, Yu AL, Tang J, Wang CL, et al
    MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30640.
    PubMed     Abstract available

    November 2017
  37. LO JH, Chen TT
    Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231).
    Exp Cell Res. 2017 Nov 27. pii: S0014-4827(17)30628.
    PubMed     Abstract available

    October 2017
  38. ZHU S, Wang X, Wang J, Lin J, et al
    CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
    Exp Cell Res. 2017 Oct 17. pii: S0014-4827(17)30561.
    PubMed     Abstract available

  39. DE S, Das S, Mukherjee S, Das S, et al
    Establishment of Twist-1 and TGFBR2 as direct targets of microRNA-20a in Mesenchymal to Epithelial Transition of Breast Cancer Cell-line MDA-MB-231.
    Exp Cell Res. 2017 Oct 4. pii: S0014-4827(17)30532.
    PubMed     Abstract available

    September 2017
  40. CASCIONE M, De Matteis V, Toma CC, Pellegrino P, et al
    Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
    Exp Cell Res. 2017 Sep 19. pii: S0014-4827(17)30500.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.